MedTrace Logo

Femoral Triangle Block: Early Mobilization and Postoperative Analgesia After Total Knee Arthroplasty

NCT03518450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2020-01-22

No results posted yet for this study

Summary

The objective of this trial is to compare the efficacy of three different nerve blocks as an analgesic option after total knee arthroplasty (TKA), based on muscle strength, mobilization and pain.

The Adductor Canal Block has been proposed as an equally effective technique to the Femoral Nerve Block in terms of pain control after a TKA, with the benefit of preserving muscle function. We hypothesize that a block performed at the apex of the femoral triangle would best balance analgesia with quadriceps function.

Conditions

  • Arthroplasty, Replacement, Knee
  • Anesthesia, Conduction
  • Pain, Postoperative
  • Ultrasonography, Interventional

Interventions

PROCEDURE

Apex Femoral Triangle Block

Nerve block that aims the vastus medialis nerve, the saphenous nerve and the anterior femoral cutaneous nerve.

PROCEDURE

Femoral Nerve Block

Regional anesthetic technique that blocks the sensory and motor information of the femoral nerve (and it's branches).

PROCEDURE

Adductor Canal Block

Interfascial block that targets mainly the saphenous nerve.

Sponsors & Collaborators

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Alfons Biarnes Suñe, M.D., Ph.D.

  • Carlos I Salvadores de Arzuaga, M.D.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2019-04-13
Completion
2019-10-15

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03518450 on ClinicalTrials.gov